Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;49(2):760-2.
doi: 10.1128/JCM.01775-10. Epub 2010 Nov 24.

Detection of yellow fever 17D genome in urine

Cristina Domingo, Sergio Yactayo, Edinam Agbenu, Maurice Demanou, Axel R Schulz, Katjana Daskalow, Matthias Niedrig

Detection of yellow fever 17D genome in urine

Cristina Domingo et al. J Clin Microbiol. 2011 Feb.
No abstract available

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Detection of YF-17D genome in urine of healthy vaccinees (upper graph) or vaccinees with suspected adverse events (lower graph). Black bars represent positive samples; dotted bars represent negative samples. The black line indicates the percentage of positive samples from the total number of samples assayed at this time point. ∗, percentages could be biased by the small number of samples.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Anonymous 2010. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep. 59:1–27 - PubMed
    1. Bae H. G., et al. 2005. Analysis of two imported cases of yellow fever infection from Ivory Coast and the Gambia to Germany and Belgium. J. Clin. Virol. 33:274–280 - PubMed
    1. Bae H. G., Nitsche A., Teichmann A., Biel S. S., Niedrig M. 2003. Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J. Virol. Methods 110:185–191 - PubMed
    1. Belsher J. L., et al. 2007. Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease. Vaccine 25:8480–8485 - PMC - PubMed
    1. CDC 11 July 2007, posting date Special testing for selected patients with severe adverse events potentially related to yellow fever vaccination. Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA: http://www.cdc.gov/ncidod/YellowFeven/vaccine/special-testing.htm

MeSH terms